Clinical pharmacokinetics of nebivolol: a systematic review
Drug Metab Rev. 2023 Nov;55(4):428-440. doi: 10.1080/03602532.2023.2271195. Epub 2023 Oct 28.ABSTRACTNebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile dysfunction, vascular disease, and diabetes mellitus. This review investigated the data regarding pharmacokinetic (PK) parameters, drug-drug interactions, dextrorotatory (D), and levorotatory (L) stereoisomers of nebivolol. The articles related to the PK of nebivolol were retrieved by searching the five databases; Google Scholar, PubMed, Cochrane Library, ScienceDirect, and EBSCO. A total of 20 studies comprising plasma concentration-time profile data following the nebivolol's oral and intravenous (IV) administration were included. The area under the concentration-time curve from zero to infinity (AUC0-∞) was 15 times greater in poor metabolizers (PMs) than in extensive metabolizers (EMs). In hypertensive patients, L-nebivolol expressed a higher maximum plasma concentration (Cmax) than D-nebivolol, i.e. 2.5 ng/ml vs 1.2 ng/ml. The AUC0-∞ of nebivolol was 3-fold greater in chronic kidney disease (CKD). The clearance (CL) was increased in obese than in controls from 51.6 ± 11.6 L/h to 71.6 ± 17.4 L/h when 0.5 mg/ml IV solution was infused. Nebivolol showed higher Cmax, AUC0-∞ and half-life (t1/2) when co-administered with bupropion, duloxetine, fluvoxamine, paroxetine, lansoprazole, and fluoxetine. This concise review of nebivolol would be advantageous in assessing all PK parameter...
Source: Drug Metabolism Reviews - Category: Drugs & Pharmacology Authors: Nida Hanif Ammara Zamir Imran Imran Hamid Saeed Abdul Majeed Anees Ur Rehman Waseem Ashraf Faleh Alqahtani Muhammad Fawad Rasool Source Type: research
More News: Bupropion | Cardiology | Cardiovascular | Chronic Kidney Disease | Cymbalta | Databases & Libraries | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Erectile Dysfunction | Fluoxetine | Heart | Heart Failure | Hypertension | Lansoprazole | Obesity | Paroxetine | Paxil | Prevacid | Prozac | Study | Urology & Nephrology | Wellbutrin